Surfing the MASH Tsunami
Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL
Surfing the MASH Tsunami
S2 E2.1 - Innovations in Telemedicine and Mobile Technology can improve care for NAFLD patients
Innovations in Telemedicine and Mobile Technologies are already changing patient care in ways that will remain and expand in the "New Normal" after the COVID-19 pandemic is less urgent.
Our guest, Dr. Manal Abdelmalek discusses how a rough week in patient-management led her to envision innovative ways to incorporate telemedicine and mobile technologies such as FibroScan and non-invasive blood tests like NIS-4, ELF, and FIB-4, into patient care. Stephen Harrison and Louise Campbell build on Manal’s concept.